Literature DB >> 23455500

Competition for antigen at the level of the APC is a major determinant of immunodominance during memory inflation in murine cytomegalovirus infection.

Lila A Farrington1, Tameka A Smith, Finn Grey, Ann B Hill, Christopher M Snyder.   

Abstract

The unique ability of CMV to drive the expansion of virus-specific T cell populations during the course of a lifelong, persistent infection has generated interest in the virus as a potential vaccine strategy. When designing CMV-based vaccine vectors to direct immune responses against HIV or tumor Ags, it becomes important to understand how and why certain CMV-specific populations are chosen to inflate over time. To investigate this, we designed recombinant murine CMVs (MCMVs) encoding a SIINFEKL-enhanced GFP fusion protein under the control of endogenous immediate early promoters. When mice were infected with these viruses, T cells specific for the SIINFEKL epitope inflated and profoundly dominated T cells specific for nonrecombinant (i.e., MCMV-derived) Ags. Moreover, when the virus encoded SIINFEKL, T cells specific for nonrecombinant Ags displayed a phenotype indicative of less frequent exposure to Ag. The immunodominance of SIINFEKL-specific T cells could not be altered by decreasing the number of SIINFEKL-specific cells available to respond, or by increasing the number of cells specific for endogenous MCMV Ags. In contrast, coinfection with viruses expressing and lacking SIINFEKL enabled coinflation of T cells specific for both SIINFEKL and nonrecombinant Ags. Because coinfection allows presentation of SIINFEKL and MCMV-derived Ags by different cells within the same animal, these data reveal that competition for, or availability of, Ag at the level of the APC determines the composition of the inflationary response to MCMV. SIINFEKL's strong affinity for H-2K(b), as well as its early and abundant expression, may provide this epitope's competitive advantage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23455500      PMCID: PMC3608834          DOI: 10.4049/jimmunol.1203151

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  The enemy within: keeping self-reactive T cells at bay in the periphery.

Authors:  Lucy S K Walker; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2002-01       Impact factor: 53.106

2.  26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

Authors:  P Cascio; C Hilton; A F Kisselev; K L Rock; A L Goldberg
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

3.  Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells.

Authors:  S B Boppana; W J Britt
Journal:  Virology       Date:  1996-08-01       Impact factor: 3.616

4.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.

Authors:  E McLaughlin-Taylor; H Pande; S J Forman; B Tanamachi; C R Li; J A Zaia; P D Greenberg; S R Riddell
Journal:  J Med Virol       Date:  1994-05       Impact factor: 2.327

6.  Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

Authors:  Felicia D Goodrum; Craig T Jordan; Kevin High; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

7.  Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses.

Authors:  Urs Karrer; Markus Wagner; Sophie Sierro; Annette Oxenius; Hartmut Hengel; Tilman Dumrese; Stefan Freigang; Ulrich H Koszinowski; Rodney E Phillips; Paul Klenerman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  The context of gene expression defines the immunodominance hierarchy of cytomegalovirus antigens.

Authors:  Iryna Dekhtiarenko; Michael A Jarvis; Zsolt Ruzsics; Luka Čičin-Šain
Journal:  J Immunol       Date:  2013-03-04       Impact factor: 5.422

9.  T cells compete for access to antigen-bearing antigen-presenting cells.

Authors:  R M Kedl; W A Rees; D A Hildeman; B Schaefer; T Mitchell; J Kappler; P Marrack
Journal:  J Exp Med       Date:  2000-10-16       Impact factor: 14.307

10.  Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues.

Authors:  Rafaela Holtappels; Jürgen Podlech; Marcus-Folker Pahl-Seibert; Markus Jülch; Doris Thomas; Christian O Simon; Markus Wagner; Matthias J Reddehase
Journal:  J Exp Med       Date:  2003-12-29       Impact factor: 14.307

View more
  27 in total

1.  Intratumoral Infection with Murine Cytomegalovirus Synergizes with PD-L1 Blockade to Clear Melanoma Lesions and Induce Long-term Immunity.

Authors:  Dan A Erkes; Guangwu Xu; Constantine Daskalakis; Katherine A Zurbach; Nicole A Wilski; Toktam Moghbeli; Ann B Hill; Christopher M Snyder
Journal:  Mol Ther       Date:  2016-06-10       Impact factor: 11.454

2.  A CD8 T-cell epitope variant enhances immune targeting to a recombinant picornavirus vaccine antigen.

Authors:  Michael P Bell; Danielle N Renner; Aaron J Johnson; Kevin D Pavelko
Journal:  Viral Immunol       Date:  2014-07-15       Impact factor: 2.257

Review 3.  Cytomegalovirus memory inflation and immune protection.

Authors:  Luka Cicin-Sain
Journal:  Med Microbiol Immunol       Date:  2019-04-10       Impact factor: 3.402

Review 4.  CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.

Authors:  Andrea J Sant; Anthony T DiPiazza; Jennifer L Nayak; Ajitanuj Rattan; Katherine A Richards
Journal:  Immunol Rev       Date:  2018-07       Impact factor: 12.988

Review 5.  Original Antigenic Sin Response to RNA Viruses and Antiviral Immunity.

Authors:  Mee Sook Park; Jin Il Kim; Sehee Park; Ilseob Lee; Man-Seong Park
Journal:  Immune Netw       Date:  2016-10-25       Impact factor: 6.303

6.  The Chemokine Receptor CXCR3 Promotes CD8+ T Cell Accumulation in Uninfected Salivary Glands but Is Not Necessary after Murine Cytomegalovirus Infection.

Authors:  Sofia Caldeira-Dantas; Thomas Furmanak; Corinne Smith; Michael Quinn; Leyla Y Teos; Adam Ertel; Drishya Kurup; Mayank Tandon; Ilias Alevizos; Christopher M Snyder
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

7.  Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.

Authors:  Holly Turula; Mayank Tandon; Michael Quinn; Berthony Deslouches; Toktam Moghbeli; Christopher M Snyder
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

Review 8.  Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity.

Authors:  Dan A Erkes; Nicole A Wilski; Christopher M Snyder
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 9.  T cell responses to cytomegalovirus.

Authors:  Paul Klenerman; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2016-04-25       Impact factor: 53.106

10.  The Neonatal CD8+ T Cell Repertoire Rapidly Diversifies during Persistent Viral Infection.

Authors:  Vanessa Venturi; Kito Nzingha; Timothy G Amos; Wisler C Charles; Iryna Dekhtiarenko; Luka Cicin-Sain; Miles P Davenport; Brian D Rudd
Journal:  J Immunol       Date:  2016-01-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.